Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brasasard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Mar 11. pii: S0190-9622(19)30367-6. doi: 10.1016/j.jaad.2019.02.067. [Epub ahead of print]

PMID:
30872156
2.

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, Intralesional, and Systemic medical Management.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brasasard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y.

J Am Acad Dermatol. 2019 Mar 11. pii: S0190-9622(19)30368-8. doi: 10.1016/j.jaad.2019.02.068. [Epub ahead of print]

PMID:
30872149
3.

Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.

Jaque A, Mereniuk A, Walsh S, Shear NH, Sade S, Zagorski B, Alhusayen R.

Int J Dermatol. 2019 Feb 14. doi: 10.1111/ijd.14391. [Epub ahead of print]

PMID:
30761533
4.

Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study.

Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, Paterson JM, Cheng SY, Jabbari S, Campbell W, Bernatsky S, Gladman DD, Tu K.

Arthritis Care Res (Hoboken). 2018 Sep 1. doi: 10.1002/acr.23743. [Epub ahead of print]

PMID:
30171803
5.

Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.

Chan AW, Fung K, Austin PC, Kim SJ, Singer LG, Baxter NN, Alhusayen R, Rochon PA.

Am J Transplant. 2019 Feb;19(2):522-531. doi: 10.1111/ajt.14966. Epub 2018 Jul 6.

PMID:
29900669
6.

Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study [Formula: see text].

Shah N, Alhusayen R, Walsh S, Shear NH.

J Cutan Med Surg. 2018 Sep/Oct;22(5):484-487. doi: 10.1177/1203475418781336. Epub 2018 Jun 1.

PMID:
29855201
7.

Representation and treatment allocation of racial groups in dermatologic therapy trials: A 2-year review of the literature.

Park CK, Alhusayen R.

Dermatol Online J. 2018 Feb 15;24(2). pii: 13030/qt62d6v7c5. Review.

8.

Changes in the Practice Patterns and Demographics of Ontario Dermatologists.

Micieli R, Alhusayen R.

J Cutan Med Surg. 2018 Jul/Aug;22(4):390-399. doi: 10.1177/1203475418762719. Epub 2018 Mar 8.

PMID:
29519145
9.

Early-stage mycosis fungoides screening investigations: a retrospective analysis of 440 cases.

Bawazir MA, Almohideb M, Walsh S, Shear NH, Alhusayen R.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e217-e218. doi: 10.1111/jdv.14735. Epub 2018 Jan 3. No abstract available.

PMID:
29220538
10.

Severe Physical Complications among Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Olteanu C, Shear NH, Chew HF, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, Finkelstein Y, Burnett M, Ziv M, Sade S, Jeschke MG, Dodiuk-Gad RP.

Drug Saf. 2018 Mar;41(3):277-284. doi: 10.1007/s40264-017-0608-0.

PMID:
29052094
11.

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD.

Exp Dermatol. 2018 Jan;27(1):104-112. doi: 10.1111/exd.13445. Epub 2017 Nov 15.

PMID:
28898476
12.

Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.

Almohideb M, Walsh S, Walsh S, Shear N, Alhusayen R.

Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):604-612. doi: 10.1016/j.clml.2017.06.015. Epub 2017 Jun 19.

PMID:
28711574
13.

The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Shah A, Alhusayen R, Amini-Nik S.

Inflamm Res. 2017 Nov;66(11):931-945. doi: 10.1007/s00011-017-1074-y. Epub 2017 Jun 27. Review.

PMID:
28656364
14.

Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.

Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y.

J Cutan Med Surg. 2017 Nov/Dec;21(6):513-524. doi: 10.1177/1203475417716117. Epub 2017 Jun 22. Review.

PMID:
28639459
15.

Observations from our evaluation of bodyweight changes after initiation of a biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Shear NH, Alhusayen R, Fernandez-Obregon A, Kimball AB, Menter A, Wu JJ, Goyal K, Patel H, Lin R, Armstrong AW.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):e544-e547. doi: 10.1111/jdv.14414. Epub 2017 Jul 12. No abstract available.

PMID:
28622413
16.

Qu’est-ce que l’hidradénite suppurée?

Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J.

Can Fam Physician. 2017 Feb;63(2):e86-e93. Review. French.

PMID:
28209697
Free PMC Article
17.

What is hidradenitis suppurativa?

Lee EY, Alhusayen R, Lansang P, Shear N, Yeung J.

Can Fam Physician. 2017 Feb;63(2):114-120. Review.

18.

Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF).

Alavi A, Adam DN, Alhusayen R, Boucier M, Brassard A, Coutts P, Gooderham M, Gulliver W, Hong CH, Lynde C, Marcoux D, Papp K, Poulin Y, Sibbald RG, Shear NH.

J Cutan Med Surg. 2016 Nov;20(6):613-615. No abstract available.

PMID:
27821541
19.

Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa.

Wong D, Walsh S, Alhusayen R.

J Am Acad Dermatol. 2016 Nov;75(5):1059-1062. doi: 10.1016/j.jaad.2016.06.001. No abstract available.

PMID:
27745633
20.

Risk of Malignancy in Dermatomyositis and Polymyositis.

Qiang JK, Kim WB, Baibergenova A, Alhusayen R.

J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20. Review.

PMID:
27534779
21.

Acitretin.

Tan MG, Shear NH, Walsh S, Alhusayen R.

J Cutan Med Surg. 2017 Jan/Feb;21(1):48-53. doi: 10.1177/1203475416659858. Epub 2016 Jul 19.

PMID:
27432818
22.

Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Dodiuk-Gad RP, Olteanu C, Feinstein A, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, Finkelstein Y, Burnett M, Sade S, Cartotto R, Jeschke M, Shear NH.

Br J Dermatol. 2016 Aug;175(2):422-4. doi: 10.1111/bjd.14799. Epub 2016 Jul 21. No abstract available.

PMID:
27292197
23.

Validating the diagnostic code for acne in a tertiary care dermatology centre.

Ejaz A, Malaiyandi V, Kim WB, Rogalska T, Alhusayen R.

Eur J Dermatol. 2015 Sep-Oct;25(5):469-71. doi: 10.1684/ejd.2015.2606.

PMID:
26518997
24.

Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.

Alhusayen R, Shear NH.

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S42-6. doi: 10.1016/j.jaad.2015.07.049. Review.

PMID:
26470615
25.

Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options.

Wang SC, Wang SC, Alavi A, Alhusayen R, Bashash M, Sibbald RG.

Adv Skin Wound Care. 2015 Aug;28(8):372-80; quiz 381-2. doi: 10.1097/01.ASW.0000466712.21948.8a. Review.

PMID:
26181861
26.

Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features.

Wang SC, Wang SC, Sibbald RG, Alhusayen R, Bashash M, Alavi A.

Adv Skin Wound Care. 2015 Jul;28(7):325-32; quiz 333-4. doi: 10.1097/01.ASW.0000465674.34810.e9. Review.

PMID:
26080019
27.

Skin Necrosis from Intra-articular Hyaluronic Acid Injection.

Kim WB, Alhusayen RO.

J Cutan Med Surg. 2015 Mar-Apr;19(2):182-4. doi: 10.2310/7750.2014.14081. Epub 2015 Mar 11.

PMID:
25775637
28.

Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.

Tseng E, Alhusayen R, Sade S, Buckstein R, Prica A.

Br J Haematol. 2015 May;169(4):461. doi: 10.1111/bjh.13341. Epub 2015 Mar 12. No abstract available.

PMID:
25765235
29.

Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

Alhusayen RO, Juurlink DN, Mamdani MM, Morrow RL, Shear NH, Dormuth CR; Canadian Drug Safety and Effectiveness Research Network.

J Invest Dermatol. 2013 Apr;133(4):907-12. doi: 10.1038/jid.2012.387. Epub 2012 Oct 25.

30.

Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?

Alhusayen R, Shear NH.

Am J Clin Dermatol. 2012 Oct 1;13(5):283-91. doi: 10.2165/11631880-000000000-00000. Review.

PMID:
22676319
31.

Case report of primary rectal melanoma and review of the etiology of melanoma.

Fratesi L, Alhusayen R, Walker J.

J Cutan Med Surg. 2008 May-Jun;12(3):117-20. Review.

PMID:
18544294
32.

Becker nevus on the lower limb: case report and review of the literature.

Alhusayen R, Kanigsberg N, Jackson R.

J Cutan Med Surg. 2008 Jan-Feb;12(1):31-4. Review.

PMID:
18258146

Supplemental Content

Loading ...
Support Center